120 related articles for article (PubMed ID: 29958195)
61. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
62. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.
Cubiella J; Marzo-Castillejo M; Mascort-Roca JJ; Amador-Romero FJ; Bellas-Beceiro B; Clofent-Vilaplana J; Carballal S; Ferrándiz-Santos J; Gimeno-García AZ; Jover R; Mangas-Sanjuán C; Moreira L; Pellisè M; Quintero E; Rodríguez-Camacho E; Vega-Villaamil P;
Gastroenterol Hepatol; 2018 Nov; 41(9):585-596. PubMed ID: 30245076
[TBL] [Abstract][Full Text] [Related]
63. [Colorectal cancer screening].
Castells A
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():64-70. PubMed ID: 26520198
[TBL] [Abstract][Full Text] [Related]
64. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
[TBL] [Abstract][Full Text] [Related]
65. Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery.
Yoshida N; Tamaoki Y; Baba Y; Sakamoto Y; Miyamoto Y; Iwatsuki M; Shono T; Miyamoto H; Imuta M; Kurashige J; Sawayama H; Tokunaga R; Watanabe M; Sasaki Y; Yamashita Y; Baba H
Int J Clin Oncol; 2016 Dec; 21(6):1079-1084. PubMed ID: 27368336
[TBL] [Abstract][Full Text] [Related]
66. [Colorectal cancer screening: evidence and implementation].
Brenner H; Hoffmeister M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):302-6. PubMed ID: 24562704
[TBL] [Abstract][Full Text] [Related]
67. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].
Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894
[TBL] [Abstract][Full Text] [Related]
68. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
[TBL] [Abstract][Full Text] [Related]
69. Prevalence of colorectal cancer and its precursor lesions in symptomatic and asymptomatic patients undergoing total colonoscopy: results of a large prospective, multicenter, controlled endoscopy study.
Blumenstein I; Tacke W; Bock H; Filmann N; Lieber E; Zeuzem S; Trojan J; Herrmann E; Schröder O
Eur J Gastroenterol Hepatol; 2013 May; 25(5):556-61. PubMed ID: 23283303
[TBL] [Abstract][Full Text] [Related]
70. Comparative effectiveness of screening strategies for colorectal cancer.
Barzi A; Lenz HJ; Quinn DI; Sadeghi S
Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
[TBL] [Abstract][Full Text] [Related]
71. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
72. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.
Kim NH; Jung YS; Lim JW; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2019 May; 89(5):1037-1043. PubMed ID: 30684602
[TBL] [Abstract][Full Text] [Related]
73. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
[TBL] [Abstract][Full Text] [Related]
74. Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history.
Morois S; Cottet V; Racine A; Clavel-Chapelon F; Carbonnel F; Bastide N; Boutron-Ruault MC
Cancer Causes Control; 2014 Oct; 25(10):1329-36. PubMed ID: 25048603
[TBL] [Abstract][Full Text] [Related]
75. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
[TBL] [Abstract][Full Text] [Related]
76. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
[TBL] [Abstract][Full Text] [Related]
77. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
78. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
79. Screening for Colorectal Cancer.
Patel SG; Dominitz JA
Ann Intern Med; 2024 Apr; 177(4):ITC49-ITC64. PubMed ID: 38588547
[TBL] [Abstract][Full Text] [Related]
80. How much can screening reduce colorectal cancer mortality in Japan? Scenario-based estimation by microsimulation.
Kamo KI; Fukui K; Ito Y; Nakayama T; Katanoda K
Jpn J Clin Oncol; 2022 Mar; 52(3):221-226. PubMed ID: 34897471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
